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Study of the control of growth and differentiation of macrophages has been greatly 
facilitated in  recent years by  the  development of assays for granulocyte-macrophage 
progenitor  cells  (1,  2)  and  for  factors  regulating  in  vitro  growth  and  production  of 
macrophages.  Two  factors whose  properties and  action on  mouse  cells have  been  de- 
scribed in some detail are macrophage growth factor (MGF) ~ (3-5), which stimulates the 
proliferation of peritoneal macrophages, and colony-stimulating factor (CSF) (6-8), which 
stimulates the differentiation of individual progenitor cells from bone marrow,  spleen, 
and  blood  to  colonies  of granulocytes  and  macrophages.  Both  factors  have  similar 
properties, have  been found in similar sources,  and  require the presence of serum for 
their in vitro effects.  However,  there are marked differences in the assay systems for 
MGF and CSF. In the MGF assay, adherent peritoneal cells from mice intraperitoneally 
injected with soluble starch 4 days previously are cultured on glass in liquid medium. In 
the presence of MGF, a  proportion of these cells (up to 95%) incorporate [3H]thymidine 
and  divide.  The  MGF activity is  determined from  autoradiographs  and  expressed  as 
percent of total cells labeled (3). In the CSF assay, normal mouse bone marrow cells are 
cultured in semisolid medium. In the presence of CSF, approximately one-two hundreth 
of the plated nucleated  cells can  form  colonies,  and  activity is determined  by colony 
counts. Thus, for the MGF assay system the test appears to be a  proliferative response, 
while  for  the  CSF  assay  system  the  test  is  a  response  involving  proliferation  and 
differentiation. 
In the mouse system, MGF has been found in medium conditioned by certain mouse 
fibroblastic cell lines  and  passaged  embryo  cells, but  not from  lines of rat,  hamster, 
rabbit, monkey, or human origin or from mouse nonfibroblastic lines (4). It is also found 
in the ascitic fluid of mice (9) and in trypsin digests from mitotic and S-phase L cells (10). 
* Supported by grants from the Medical Research Council of Canada,  the National Cancer 
Institute of Canada, Grant VC-73Q from the American Cancer Society, and Training Grant CA- 
05163 (to M. Cifone) from the National Cancer Institute. 
$ Present address: Massachusetts Institute for Technology, Center for Cancer Research, Cam- 
bridge, Mass. 02139. 
§ Present address: Department of Pathology, New York University Medical Center, New York 
10016. 
1Abbreviations  used  in  this paper:  BSA,  bovine serum  albumin;  CFA,  complete Freund's 
adjuvant; CFU-C, CSF-dependent colony-forming unit;  Con A, Concanavalin A;  CSF, colony- 
stimulating factor; FCS, fetal calf serum; MEM, minimal essential medium; MGF, macrophage 
growth factor; PBS, phosphate-buffered saline; PEG, polyethylene glycol; TPCK, L-l-tosylamide- 
2-phenylethyl-ehloromethyl ketone; Ve/Vo, elution volume to void volume ratio. 
THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE"  VOLUME 143,  1976  631 632  FACTORS  REGULATING  MACROPHAGE  PRODUCTION  AND  GROWTH 
MGF in L-cell-conditioned medium is resistant  to inactivation by a  variety of enzymes 
including nucleases and proteases and to heat treatment with periodate (3).  CSF has been 
found in similar sources and also in the serum and urine of mouse and man.  CSFs in the 
medium  conditioned by L  cells (11),  mouse embryo fibroblasts  (12),  or human  urine  (8) 
share the properties mentioned above for MGF. In addition, it has been shown that CSFs 
from the latter sources are sialic acid-containing glycoproteins of mol wt 45,000-70,000  (8) 
with ion-exchange and gel-filtration characteristics  similar to MGF (4,  8,  11,  12). 
In view of these physical similarities and because of the early appearance of 
macrophages  in mouse colonies stimulated by CSF from these sources (13),  it 
was of interest  to determine  whether  the  MGF  and  CSF assay  systems  were 
detecting the same molecule(s). Part of this interest stems from the observations 
that  CSF and  MGF  are produced in many  immunological  reactions  in  which 
macrophages and possibly macrophage proliferation are important (14-16). This 
paper demonstrates an identity of sources, biological properties, physicochemi- 
cal behaviour,  and reactivity  to antibody for both MGF and CSF.  Methods for 
the purification of active material  from serum-free  L-cell-conditioned  medium 
and the preparation  and some properties of antibody to this material  are  also 
described. 
Materials and Methods 
MGF Assay.  6-12-wk-old male C57BL/6J mice (The Jackson Laboratory, Bar Harbor, Maine) 
were injected intraperitoneally with  1.5  ml of a  2% soluble starch  suspension  (Mann  Research 
Labs,  Inc., Orangeburg,  N. J.) in phosphate-buffered  saline (PBS).  After 4 days, the mice were 
killed with ether, and their peritoneal cavities were washed with two 4-ml vol of minimal essential 
medium  (MEM,  Auto-Pow  medium,  Flow  Laboratories,  Inc.,  Rockville,  Md.)  containing  1% 
heparin. The cells were centrifuged (800g, 10 min), washed twice in 1 vol of PBS, resuspended in 
MEM containing 10% FCS, counted in leukocyte counting fluid, and seeded in Lab Tek 8 chamber 
slides (Miles Laboratories,  Inc.  Elkhart,  Ind.)  at 5  x  104 nucleated cells/cm  2.  30 min later the 
medium was suctioned off to reduce the numbers of lymphocytes and flbroblasts in the culture. 
The attached cells were washed twice with PBS and refed. 1-4 days after seeding, culture medium 
in wells was replaced with 0.5 ml of medium containing samples and [3H]thymidine (sp act 52.2 Ci/ 
mmol) at 0.2/~Ci/ml. Medium used for preparation and incubation of cultures was TES-HEPES- 
buffered Eagles medium pH 7.6 (17) containing 10% "pretested" (5) fetal calf serum (FCS, Flow 
Laboratories Inc.), penicillin (100 U/ml), and streptomycin (0.05  ~tg/ml).  Duplicate culture wells 
were  set  up  for each  sample  tested.  After 5  days  incubation  at  37°C  in  10%  CO2  in  air  in  a 
humidified incubator,  cells were washed  with  PBS,  fixed in Carnoy's solution for 20  min and 
washed with ethanol.  Dry slides were dipped in Kodak NTB2 nuclear track emulsion (Eastman 
Kodak  Co.,  Rochester,  N.  Y.),  dried  at  room  temperature,  and  left  2  days  in  sealed  boxes 
containing  a  dessicant  at  4°C  for  exposure  before  development  with  Kodak  D-19  developer 
(Eastman Kodak). The developed slides were fixed in Amflx (May & Baker LTD., Montreal, Que- 
bec) and  stained with Giemsa. The percentage of labeled cells was determined microscopically 
under 400 magnification by counting at least 300 cells in each culture well. 
CSF Assay.  The techniques and media used in the agar culture of mouse bone marrow cells 
and the use of such cultures to assay CSF have been reported in full elsewhere (18). Sterile samples 
(<0.2 ml) were each mixed in duplicate 35-mm Petri dishes (Falcon Plastics, Oxnard, Calif.) with 1 
ml of agar medium containing 75,000  nucleated bone marrow cells from adult LAF~ mice (The 
Jackson Laboratory).  The medium used in these experiments was alpha-MEM (19) including 5% 
(vol/vol) horse serum,  10% (vol/vol) fetal calf serum (Flow Laboratories),  10% (vol/vol) trypticase 
soy broth (Baltimore Biological Laboratories, Cockeysville, Md.), 75 ~g/ml DEAE dextran (Phar- 
macia,  Uppsala,  Sweden),  5  x  10 -~ M  mercaptoethanol,  0.4%  Bacto-Agar (Difco Laboratories, 
Detroit, Mich.) and additional asparagine  (20  ~tg added/ml of medium), and glutamine (0.29  mg 
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CO2 in air (pH 7.2).  After 7 days of incubation colony counts were performed at 25 magnification 
using dark field on an Olympus dissecting microscope. Colony size ranged from 50-2,000 cells. 
Conditioned  Media  and  Sources  of Activity.  Serum  containing  media  conditioned  by  the 
following cell lines were used: Human WI38, normal embryonic fibroblasts (20); NS20, a choliner- 
gic clone of mouse neuroblastoma cells (21); IC21, an SV4o-transformed line of peritoneal macro- 
phages derived from C57BL/6J mice (22); L-5178Y, a  mouse lymphoma induced by methylcholan- 
threne (23);  and embryo fibroblasts from BALB/c mice (24) and L 60 T cells,  a  clonal isolate of 
mouse L cells (25) (for standard L-cell-conditioned medium). Ehrlich ascites fluid was prepared by 
intraperitoneal injection of 5 ×  10~-107 Ehrlich ascites cells (26) into 10-16-wk-old C57BL/6J male 
mice. The fluid was collected after 13 days, left at room temperature for 6 h, then centrifuged at 
1,800 g, the supernate collected and filtered through a  0.22 ~m filter (Millipore Corp.,  Bedford, 
Mass.).  Freund  ascites  fluid  was  prepared  by  intraperitoneal  injection of 1.5  ml  of complete 
Freund's adjuvant (CFA) (Difco Laboratories) into 10-16-wk-old C57BL/6J male mice. This ascites 
fluid was harvested in the same way as the Ehrlich ascites fluid. 
The L-cell trypsin digest was prepared by treating confluent cultures in 160 cm  2 glass bottles 
with 0.1% trypsin (Flow Laboratories) 24 h after plating at 37°C. After 5 min, trypsinization of the 
cells was inhibited by addition of FCS; the medium was harvested and filtered through a 0.22 ~m 
filter (Millipore Corporation). Endotoxin mouse serum and normal mouse serum were separated 
from blood obtained from LAF~ mice (Jackson Laboratory). For endotoxin mouse serum the mice 
were given an intraperitoneal injection of 5 p~g Escherichia coli lipopolysaccharide (Difco Labora- 
tories) and bled 4 h  later (27).  Stage VI human urinary CSF was purified from human urine as 
described elsewhere (8) and possessed an activity of 3  ×  107 colonies per mg protein. Extract of 
pregnant mouse uterus was prepared from pregnant BALB/c mice as described earlier (28). 
Purification  of CSF  from  L-Cell-Conditioned  Medium.  L  cells  were  passaged  in  spinner 
cultures of alpha medium containing 10% FCS (Flow Laboratories). For production of serum-free- 
conditioned medium for purification of CSF, cells were collected from the spinner flask, washed 
twice in serum-free alpha medium, and seeded at 2 x  105 cells/ml in 75 cm  2 plastic bottles (Falcon 
Plastics) each containing 40 ml of serum-free alpha medium.  After 7 days incubation at 37°C  in 
10% CO2 in air in a humidified incubator, the medium was collected by decantation, concentrated 
approximately 10-fold by vacuum rotary evaporation (29), dialyzed against distilled water (3 ×  20 
volume changes, 4°C),  centrifuged (1,500 g,  10 min), and the precipitate discarded. The superna- 
tant fluid was further concentrated to a small volume by vacuum rotary evaporation. 5-10 liters of 
conditioned medium could be made and processed in this way to yield a  final volume of approxi- 
mately 10 ml. This material, although substantially purified from the unconcentrated conditioned 
medium,  was  designated  as  starting material  for the purification.  The starting material  was 
dialyzed  against 0.1  M  Tris-HC1 pH  7.4  and chromatographed on a  DEAE  cellulose (Eastman 
Kodak) column (dimensions 107 ×  2.2 cm) using linear salt gradient (0-0.8 M NaC1 in 0.1 M Tris- 
HC1 pH 7.4) elution at 4°C (Fig. 3). Active fractions were pooled (Stage I material), concentrated, 
dialyzed  against 0.03  M  Tris-HCl,  pH  7,4,  and subjected to  Sephadex  G-200  (Pharmacia  Fine 
Chemicals) gel-filtration (column dimensions 130 x  2.6 cm) in that buffer at 4°C. At this stage the 
activity was usually found in two regions (elution volume to void volume ratio, V~/V,, = 1.3-1.5 and 
V,/V,,  =  1.7-2.2)  and fractions from each of these regions separately pooled (stages IIi and IIii, 
respectively), concentrated and dialyzed against Concanavilin A (Con A) buffer (0.1 M acetate pH 
6.0 containing 1 M  NaC1,  10 -:~ M  MgC12, 10  :~ M  MnCI2,  10 -'~ M  CaCI2,  and 0.001% polyethylene 
glycol (PEG,  6,000).  Both stage IIi and IIii material were chromatographed on Con A-sepharose 
(Pharmacia Fine  Chemicals)  (column  dimensions 36  ×  1.0  cm)  in  Con A  buffer at 4°C.  After 
collection of the  unadsorbed  material,  elution  of material  bound to  the  Con  A-sepharose  was 
accomplished using 0.1 M  a-methyl-n-glucoside in Con A buffer (30).  Activity was found in both 
the  unadsorbed  (IIIi)  and  bound  (IIIii)  fractions for pool  IIi  and  similarly  for pool  IIii  (IIIiii, 
unadsorbed; IIIiv, bound) (Fig. 3). All 4 stage III pools were concentrated to approximately 2.0 ml, 
dialyzed against distilled water, and stored at -20°C. Protein estimations (31) were carried out on 
all stages of each purification. 
Each  of the stage  III  fractions was  subjected to  gradient gel  electrophoresis in  a  gradipore 
system (32) using preformed gradient gels (Ortec Inc., Oak Ridge, Tenn.). After electrophoresis of 
duplicate samples for 8 h at 75 V constant voltage, duplicate gel strips were cut out, one stained for 
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Each gel segment was eluted overnight in 1.5 ml of 0.01% PEG and the supernatant fluid assayed. 
Marker proteins (Schwarz/Mann, Orangeburg, N. Y.) radiolabeled with ~2r'I (34) were electropho- 
resed alongside samples and their position in the gel determined by counting ~2~I in fractions. 
Purification  of MGF from a  Tryptic  Digest  of L  Cells.  Similar methods were  used  for the 
purification of MGF from the tryptic digest of L cells. Stage I was Sephadex G-200 (Pharmacia Fine 
Chemicals) gel-filtration in 0.1  M  Tris-HC1,  pH  7.4,  and stage II involved stepwise elution ion 
exchange  chromatography  on  QAE  Sephadex  (Pharmacia  Fine  Chemicals),  pooling  material 
elutod with 0.3 M  NaC1 in 0.1 M Tris-HC1, pH 7.4. 
Kinetics of  Disappearance of MGF and CSF from Cultures used in their Assay.  Replicate MGF 
cultures were set up with 20% L-cell-conditioned medium in the absence of :~HTdr, and the medium 
was removed for both MGF and CSF assays at various times afterwards. In addition, replicate 1- 
ml CSF cultures were overlaid with 1 ml of liquid medium and contained 20% L-cell-conditioned 
medium throughout. Periodically, liquid overlayers were removed from cultures and assayed for 
MGF and CSF. 
Treatments.  The high molecular weight, Con A-Sepharose adherent fraction (stage IIIii L-cell 
CSF, 3.1 x  107 colonies/rag protein) was used for all experiments. Periodate treatment was carried 
out as described earlier (29).  Incubation mixtures (0.9 ml) containing stage IIIii CSF (2.4 ~g) and 
K10~ (0.01  M) in 0.1 M acetate-HC1, pH 5.0, were incubated for various times at 4°C in the dark. 
Reaction was stopped by addition of 0.1 ml of 50% sucrose. For heat inactivation, incubation tubes 
contained 0.8/zg of stage IIIii CSF in 250  /~l of 0.03 M Tris-HCl, pH 7.3.  Heating was at 90°C for 
various times. Treatment with a-chymotrypsin (Worthington Biochemical Corp., Freehold, N. J. ) 
was carried out as described earlier (35).  Incubation tubes (28  ~l) contained 0.8 p,g of stage IIIii 
CSF and 16/zg a-chymotrypsin in 0.05 M CaC12 0.05 M Tris-HC1, pH 7.3. Incubation was at 37°C 
for various times, and the reaction was stepped by addition of 2.0 ml of 2% bovine serum albumin 
(BSA) and cooling to 4°C. 
Fractionation Experiments.  Stage IIIii L-cell-conditioned medium CSF (3.1  ×  107 colonies/mg 
protein) was used for all experiments. In the gel-filtration experiments, trypsin treatment was 
effected by incubation of 15/zg stage IIIii CSF with 12.5/~g L-l-tosylamide-2-phenylethyl-chloro- 
methyl ketone (TPCK)-treated trypsin (Worthington Biochemical Corp.) in 0.05 M CaCl2 0.05 M 
Tris-HCl  pH  7.3  buffer  (0.4  ml)  in  the  presence  of a  trace  amount  of  ~'~I-BSA.  A  duplicate 
incubation was set up excluding trypsin.  After 4 h  incubation at 40°C,  0.2 ml of 10% BSA was 
added to each tube before their separate chromatography on Sephadex G-200 (column dimensions, 
90 ×  1.6 cm, conditions as for stage II of purification). Fractions were counted for ~2'~I  before assay 
to  establish that  the  trypsin  was  active  under the  conditions employed.  Polyacrylamide  disk 
electrophoresis of 5.0/zg stage IIIii CSF was performed in 7.8% polyacrylamide at a running pH of 
approximately 9.4 (36). Gradient gel electrophoresis of 12/zg (20 ~g for staining) of stage IIIii CSF, 
of 200 p.g of stage IIIi CSF, and the fractionation and assay of gels from the disk electrophoresis 
were carried out as described for stage III fractions from the purification. 
Preparation and Testing of  Rabbit Sera.  An outbred rabbit was bled twice by heart puncture to 
provide 50 ml of prebleed serum. It was then injected at multiple intradermal sites with stage IIIii 
L-cell-conditioned medium CSF (0.14 mg) emulsified in an equal volume of CFA (Difco Laborato- 
ries) (total injected volume 0.4 ml). 2 wk later an identical booster injection and thereafter further 
boosters of 0.14 mg of stage IIIii material were given in various ways at 1-2-wk intervals. At the 
same time, small blood samples were collected via the ear veins for determination of the serum 
neutralization titre. Testing of the antiserum was carried out by mixing preparations of MGF or 
CSF with the antiserum or the PBS-diluted antiserum and incubating at room temperature for 30 
min before assaying samples in both assay systems. 
Results 
Dose Response Curves.  Typical dose response curves for the standard L-cell- 
conditioned medium in both MGF and CSF assay systems are presented in Fig. 
1. The CSF assay system at certain concentrations was approximately twice as 
sensitive as the MGF assay system. A sample causing almost maximal response 
in the CSF assay could show no or low response in the MGF assay because of  the 
sigmoidal nature of the dose-response curve in the latter assay.  Inhibition at 150 
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FIG.  1.  Response to varying concentrations  of L-cell-conditioned  medium in the CSF assay 
(0) and the MGF assay (©). Each point represents the mean of  counts on two plates or wells. 
Data for the MGF assay are plotted here and elsewhere as percent labeling index after 
subtraction of  background labeling determined from cultures containing no added factor. 
high doses of conditioned medium could be seen in the MGF assay dose response 
(4). These differences between the two assay systems are important for interpre- 
tation of the results of some of the following experiments. 
Sources of  Activity.  A number of  sources for both factors have been reported. 
Some sources such as ascites fluid and endotoxin mouse serum had been tested 
in only one system. Others such as normal mouse serum were only active in the 
CSF assay. To clarify the questions raised by these data, various sources that 
had been shown to be active or inactive in one of the two systems were tested at 
the same time for both CSF and MGF activity at different concentrations. The 
results are summarized in Table I.  There was a  complete correlation between 
assays  for  the  presence  or  absence  of activity  in  all  of the  various  source 
materials assayed except for normal mouse serum where activity was low in the 
CSF assay and undetectable in the MGF assay. 
Kinetics  of Depletion  of MGF  and  CSF  Activities  in  both  Culture  Sys- 
tems.  One  biological  test  for  identity of MGF  and  CSF  is  to  compare  the 
kinetics of disappearance  of both  activities in  the  different culture systems. 
Activities of MGF and CSF in their respective assay systems have been shown to 
decrease with time of culture (5, 18). Transfer of medium from a test culture to 
fresh cells results  in decreased activity in the recipient culture.  Conditioned 
medium was incubated with either activated macrophages or mouse bone mar- 
row cells, and the rate of disappearance of both CSF and MGF activities was 
measured.  The  results  are  summarized  in  Fig.  2.  There was  no  significant 
difference between the kinetics of loss of CSF and the kinetics of loss of MGF 
during incubation with either cell population. Previous studies in both systems 
(5, 18) have shown that under the same incubation conditions in the absence of 
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TABLE  I 
Coincidence of MGF and CSF in Various Sources 
Source 
Activity 
MGF  CSF 
Human WI38  CM*  -  - 
Mouse S-20 CM  -  - 
Mouse IC-21  CM  -  - 
Mouse L-5178Y  CM  -  - 
Mouse embryo fibroblast CM  +  + 
Ehrlich ascites fluid  +  + 
Freund adjuvant ascites fluid  +  + 
L-cell trypsin digest  +  + 
Endotoxin mouse serum  +  + 
Normal mouse serum  -  -+ $ 
Stage VI human urinary CSF (8)  +  + 
* CM, 
$ Low 
conditioned medium. 
activity, below detectability in the MGF assay. 
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Fro.  2.  Kinetics of disappearance of L-cell medium CSF (0) and MGF (O) during culture 
in the MGF (a) and CSF (b) assay systems. Each point represents the mean of counts on two 
plates or wells. 
Copurification  of  CSF  and  MGF  from  L-Cell-Conditioned  Me- 
dia.  Fractionation  of L-cell-conditioned medium  pools was  carried out as sum- 
marized  in Fig. 3. Activity of fractions was followed using the CSF assay. In two 
of three  purifications,  two peaks  of activity were found at stage II, one of higher STANLEY,  CIFONE,  HEARD,  AND  DEFENDI  637 
Fro.  3.  Purification of CSF from serum-free L-cell-conditioned medium and analysis of the 
four active products  by gradient gel electrophoresis. The banding of colony-stimulating 
activity for each of the stage III fractions is represented by the filled bands adjacent to the 
photographs  of the  stained  sections of the  gel slab.  The  migration of marker  proteins 
included in the run is also indicated (Ova, ovalbumin; BSA, bovine serum albumin; (BSA)2, 
BSA dimer). 
apparent  molecular weight (i) containing  most of the activity and the other of 
lower apparent molecular weight (ii).  Passage of stage II pools through Con A- 
sepharose  columns  resulted  in  further  fractionation.  In  all  cases most of the 
activity was adsorbed to Con A-sepharose. Material that was unadsorbed (stages 
IIIi  and  IIIiii)  failed  to  bind  when  passed  through  newly  prepared  Con  A- 
sepharose  columns.  Differences in  the  size  characteristics  of the  activity  and 
stainable protein in the four active fractions resulting from the fractionation can 
be seen in the gradient gel electrophoretograms presented in Fig. 3. Separation 
under the conditions used was almost entirely due to apparent  size differences 
(32). The banding of activity in each electrophoretogram was broad and polydis- 
perse  compared  with  the  banding  of marker  proteins.  Results  of a  typical 
purification  are  summarized  in  Table  II.  It  can  be  seen  that  most  of the 
recovered activity was found  in  fraction  IIIii  (high  molecular  weight,  Con A 
adherent),  that it represented a  substantial proportion of the starting  activity, 
and  was the most purified fraction  with respect to protein.  This  fraction  was 
used in the inactivation  experiments,  in the fractionation experiments,  and to 
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TABLE II 
Purification of L-Cell CSF from 5 Liters of Serum-Free-Conditioned Medium 
Stage  Total vol-  Total  activity  colonies x  Total  protein  Yield  Specific  activ- 
ume  10_ 4  ity 
% starting  colonies/mg  × 
ml  mg  activity  10 -5 
SM*  12.00  1,780  30.35  100.0  5.9 
I  6.50  1,530  5.50  86.0  27.8 
IIi  2.45  1,320  3.19  74.2  41.4 
IIii  1.75  29  1.23  1.6  2.4 
IIIi  1.34  72  2.68  4.0  2.7 
IIIii  1.75  1,090  -<0.35  61.2  ->311.4 
IIIiii  0.28  6.4  -<0.50  0.4  ->1.3 
IIIiv  0.31  6.5  <-0.40  0.4  ->1.6 
* SM, starting material. 
Results of simultaneous assays for MGF and CSF on fractions from purifica- 
tions from L-cell-conditioned medium and a  tryptic digest of L  cells are pre- 
sented in Table III. It can be seen that, considering the inherent variability of 
the assays, there was a close correlation between results from both systems. For 
these experiments fractions were diluted for assay with a-medium which was 
shown to result in loss of both CSF and MGF activity. This loss of activity could 
be prevented by dilution in 0.01%  PEG (8), e.g., stage IIIii in  a-medium, 460 
colonies/ml, and in PEG, 23,200 colonies/ml. 
Kinetics  of Inactivation  of Purified  L-Cell  Material.  Previous studies  on 
MGF (3) and CSF (12) from mouse sources have shown that they are inactivated 
by heat or periodate treatment and relatively resistant to treatment with  a- 
chymotrypsin. There was no significant difference in the kinetics of inactivation 
between the MGF and CSF activities of stage IIIii material during incubation 
with  a-chymotrypsin or  periodate  (Fig.  4)  and  during  heating at  90°C (not 
shown). In contrast to results obtained with human urinary CSF (35), neither 
activity was lost on incubation with the high concentrations of a-chymotrypsin 
used. Similar kinetics to those for the inactivation by periodate were observed 
for the inactivation by heating at 90°C, 50% of both activities being lost after 45 
min. 
Fractionation  of the  CSF  and  MGF  Activities  of Purified  L-CeU  Mate- 
rial.  The most purified fraction (stage IIIii) was used for these experiments. On 
Sephadex G-200 gel-filtration (Fig. 5 a) the band of MGF lay under the band of 
CSF. Austin et al. (11) reported an increase in elution volume on gel filtration of 
L-cell-conditioned medium CSF previously treated with trypsin. This finding 
was confirmed in experiments in which stage IIIii material was treated with 
trypsin before gel-filtration. Furthermore, trypsin treatment increased coordi- 
nately the elution volume of CSF and MGF activities (Fig. 5 b).  Higher resolu- 
tion  analyses  of the  two  activities  in  stage  IIIii  material  were  performed, 
separating according to charge by polyacrylamide disk gel electrophoresis and 
according to size by gradient gel electrophoresis.  Cochromatography of MGF 
and CSF was observed on 6% polyacrylamide  gel electrophoresis (Fig. 5 c) and on STANLEY,  CIFONE,  HEARD,  AND  DEFENDI 
TABLE  III 
Copurification of MGF and CSF Activities from both L-cell- 
Conditioned Medium and a  Trypsin Digest of L  Cells 
Stage  CSF  MGF 
639 
colonies  x dilu-  % 1_,1" x dilu- 
tion -1  tion -l 
L-cell-conditioned medium 
I  220,200  >800 
II/  42,200  ~300 
II/i  7,800  128 
III/  17,300  254 
III/i  5,200  91 
IIIiii  4,400  105 
IIIiv  16,200  546 
Tryptic digest of  L cells$ 
SM§  NDI[  1,850 
I  4,800  360 
II  16,000  700 
* LI, labeling index. 
* Assayed independently  of the L-cell-conditioned medium  fractions; 
comparisons can be made within but not between the purifications. 
§ SM, starting  material. 
IIND, not done. 
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Fro.  5.  Cochromatography of the CSF  and MGF  activities of stage  IIIii  material  (high 
molecular weight, Con A adherent). The banding of MGF (O--O) and CSF (Q--O) on gel- 
filtration  on  Sephadex  G-200  before  (a)  and  after  (b)  treatment  with  trypsin;  on  7.8% 
polyacrylamide gel electrophoresis pH 9.4 (c) and on gradient gel electrophoresis (d).  The 
positions of the peaks of marker proteins, bovine serum albumin (BSA; 67,000 daltons), and 
BSA dimer ((BSA)~ 134,000  daltons) are also indicated. The banding of biological activity on 
gradient gel electrophoresis is shown against the Coomassie Brilliant Blue staining pattern 
for stage IIIii material. 
gradient  gel  electrophoresis  (Fig.  5  d)  where the  polydisperse  activity  bands 
coelectrophoresed with  a  polydisperse  protein  stained  band.  In  addition,  the 
MGF and CSF activities of stage IIIi  material  (high molecular weight,  Con A 
nonadherent)  were also shown to coelectrophorese on both disk electrophoresis 
and gradient gel electrophoresis (results not shown). 
Kinetics of  Antibody Production.  Repeated injection of 0.14 mg of stage IIIii 
material  with adjuvant into a rabbit produced an antiserum with neutralizing 
activity for L-cell-conditioned medium  CSF and  MGF and for human  urinary 
CSF. The kinetics of production of the neutralizing  activities of the antiserum 
are  shown  in  Fig.  6.  Neutralizing  activity for CSF  and  MGF of L-cell-condi- 
tioned medium developed simultaneously. In contrast, the neutralizing activity 
for human urinary CSF took a longer time to develop and attained a lower but 
quite  significant  titre.  There  was  no  inhibitory  effect of the  prebleed  rabbit 
serum on the CSF and MGF assays at the highest concentration of antiserum 
used.  In addition,  the untreated  antiserum  at the highest concentration  used 
had no direct effect on colony formation if preincubated with the target cells for 1 
h  at  0°C  in  the  presence  or  absence  of guinea  pig  serum  (as  a  source  of 
complement),  indicating  that  the  neutralizing  activity produced was directed 
against the factors and not the cells. 
Neutralization  by Antiserum.  The  results  of a  neutralization  titration  of 
high  titre  antiserum  against  L-cell-conditioned  medium  CSF  and  MGF  and STANLEY,  CIFONE,  HEARD,  AND  DEFENDI  641 
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Fro.  6.  Kinetics of antibody production in a  rabbit given 0.14 mg of stage IIIii material 
(high molecular weight,  Con  A  adherent)  at the times indicated (ID,  intradermally; IP, 
intraperitoneally; A, in 50% CFA). Ordinate expresses the final concentration of antiserum 
in cultures (vol/vol) required for neutralization of 50% of the activity of a near optimal dose 
of L-cell-conditioned medium (O--C), MGF assay; Q--O, CSF assay} or human urinary CSF 
(D--D. 
human urinary CSF are shown in Fig.  7.  Titration curves for L-cell medium 
CSF and MGF were coincidental and distinct from the curve for human urinary 
CSF. 
Action of Antiserum on Murine Sources of CSF.  The neutralizing activity of 
the antiserum for a  number of sources of murine CSF was tested.  With the 
exception of stage IIIiii  (low molecular weight,  Con  A  nonadherent), all  the 
stage III purification fractions (including trypsin-treated stage IIIii) were neu- 
tralized at equivalent concentrations of antiserum (0.0001% antiserum (vol/vol) 
for 50%  reduction of colony numbers). There was only partial  neutralization 
(40%) of stage IIIiii material by the antiserum even at concentrations as high as 
0.05%. The stimulating activities of mouse embryo-conditioned medium (24), 
extract of pregnant uterus (28), serum from mice injected with endotoxin (13), 
the Ehrlich ascites fluid, and the partially purified trypsin digest of L cells were 
completely neutralized by the antiserum. They exhibited identical neutraliza- 
tion curves with 50% reduction end points at 0.0001% antiserum. 
Colony Formation by Peritoneal Cells.  Lin and Stewart (37, 38) reported that 
thioglycollate-induced  peritoneal cells form macrophage colonies in agar in the 
presence of L-cell-conditioned medium. These colonies were distinct from the 
CSF-dependent colony forming units  (CFU-C)  seen in bone marrow cultures, 
being smaller and appearing later by approximately 3 wk of culture. To test 
whether the factor stimulating colony formation by peritoneal cells was related 
to CSF, starch-induced and thioglycollate-stimulated (38) peritoneal cells were 642  FACTORS  REGULATING  MACROPHAGE  PRODUCTION  AND  GROWTH 
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FIG.  7.  Neutralization by antiserum to stage IIIii  material  (bled day 54). Abscissa ex- 
presses dilution of antiserum (1 vol) in tubes containing a fixed concentration of standard L- 
cell-conditioned  medium or human urinary CSF (2 vol), Samples from tubes were assayed at 
7.5% (CSF assay) or 15% (MGF assay). L-cell-conditioned  medium MGF assay (©--©), CSF 
assay (@--O); human urinary CSF (El--D). 
TABLE  IV 
Colony Formation by Peritoneal Cells in Presence of Stage IIIii CSF* 
Cell no. plated/  1-wk colo-  3-wk colo- 
Cell source 
ml  nies*  nies§ 
CFU-C 
Starch-induced peritoneal cells  5  x  10  ~  0  35 
Thioglycollate-induced  perito-  5  x  10  '~  0  32 
neal cells 
Bone marrow  7.5  ×  104  180  NDII 
* Colonies did not appear in peritoneal cell or control bone marrow cultures in 
the absence of stage IIIii CSF. 
500-2,000  cells/colony. 
§ 50-100  cells/colony. 
II ND, not done. 
plated with the most purified CSF fraction,  stage IIIii.  The results (Table IV) 
indicate  that  purified  CSF  stimulates  colony  formation  by  both  sources  of 
peritoneal  cells,  and  that  there  was  no  colony formation  of the  CFU-C  type 
observable at 1 wk of culture. In addition, quantitatively similar results to those 
shown in  Table IV were obtained  using  an  unpurified  L-cell-conditioned me- 
dium. 
Discussion 
Very close similarity of CSF and MGF has been demonstrated by a number of 
biological,  physicochemical,  and  immunological  criteria.  In no instance  could STANLEY,  CIFONE,  HEARD,  AND  DEFENDI  643 
any significant difference between the two activities be demonstrated. 
They were coordinately present or absent in the same sources. There was 
coordinate depletion or stability of activity of conditioned medium during incu- 
bation with peritoneal macrophages or bone marrow and after inactivation with 
heat, periodate, and a-chymotrypsin. Pooled, purified fractions from CSF and 
MGF  purifications  were  active  in  both  systems.  Profiles  of MGF  and  CSF 
activities of purified CSF from polyacrylamide gel electrophoresis and gradient 
gel electrophoresis were coordinate, as were elution profiles from G-200 chroma- 
tography before and after trypsin treatment. Antibody made in rabbits against 
the most purified material available appeared against CSF and MGF  at  the 
same time. In addition, the neutralization curves of CSF and MGF were identi- 
cal using this antiserum. While absolute proof of identity must await chemical 
analysis of purified material, the data indicate that the MGF and CSF assays 
are probably detecting the same molecule. The chance that any two different 
glycoproteins would  share  the  same  source,  heterogeneity on  fractionation, 
physicochemical, biological, and antigenic properties,  as do the molecules de- 
tected by the MGF and CSF assays, is quite remote. However, it is apparent that 
the CSF assay is more sensitive than the MGF assay, and this probably explains 
earlier findings (4) that indicated that certain preparations expected to contain 
CSF were inactive in the MGF assay. 
The  heterogeneity of the  colony-stimulating activity  of L-cell-conditioned 
medium may be related to its in vitro production, since other sources of CSF 
produced in vitro possess greater heterogeneity than CSF's from body fluids (12). 
L-cell-conditioned medium could be fractionated into four quite different molec- 
ular species described by their size and ability to bind Con A. While the lower 
molecular weight species (stages IIIiii and IIIiv) represented less than 5% of the 
total recovered activity its presence in L-cell -conditioned medium has not been 
previously reported. The relation of this fraction to the higher molecular weight 
fractions (stages IIIi and IIIii) is not understood. Its gel-filtration behaviour is 
similar to the low molecular weight CSF produced in vitro by mouse lungs in the 
presence of endotoxin (39-41).  The specific activity of the most purified fraction, 
stage IIIii, (approximately 90% of the total activity recovered at stage III) was 
significantly higher than that reported for other mouse sources of CSF and MGF 
(5,  11,  12), except  for  the  low  molecular  weight  material  in  the  medium 
conditioned by mouse lung in the presence of endotoxin (40). The gradient gel 
electrophoresis experiment indicates that stage IIIii material is not completely 
purified, although a  protein band coelectrophoresed with the peak of activity. 
This band possessed an apparent mol wt of 70,000-120,000  daltons, whereas the 
high molecular weight, Con A-adherent fraction from another purification had 
an apparent mol wt of approximately 60,000 daltons. Both fractions have MGF 
activity and the 70,000-120,000  dalton band is the result of an association of the 
60,000 dalton CSF with protein(s) (E. R. Stanley and P. M. Heard, manuscript in 
preparation). Similar behaviour has been observed for human urinary CSF (42). 
The activity of highly purified human urinary CSF in the MGF assay is not 
surprising when one considers its physicochemical and immunological similar- 
ity to  L-cell-conditioned medium CSF.  These findings appear  to  enlarge the 
reported species specificity of MGF (4). 644  FACTORS  REGULATING  MACROPHAGE  PRODUCTION  AND  GROWTH 
Our studies have been concerned with a particular type of CSF and should not 
be taken to indicate that all CSF's possess MGF activity. In human urinary CSF 
and L-cell-conditioned medium CSF-stimulated murine marrow cultures there 
is  an  early appearance  of macrophages  in  colonies  (13).  Furthermore,  L-cell- 
conditioned medium CSF and human urinary CSF in their most purified states 
are glycoproteins of mol wt 45,000-70,000 which migrate electrophoretically with 
the a-globulins and albumin.  They are physicochemically distinct from the CSF 
stimulating  eosinophilic colony formation  (43) which  migrates  electrophoreti- 
cally with  the ~/-globulins,  a  low molecular  weight  CSF  (44,  45),  and  a  high 
molecular  weight  CSF  (46)  (Stanley,  unpublished  observations)  stimulating 
human granulocytic colony formation.  Inasmuch as stage IIIii material stimu- 
lates the formation of small macrophage colonies (37, 38) from thioglycollate- or 
starch-induced  peritoneal  cells,  it  is probable  that  the  factor in  L-cell-condi- 
tioned medium responsible for stimulation in these systems is CSF (MGF). The 
relation of CSF (or MGF) to the factors in L-cell-conditioned medium responsible 
for stimulating  the growth of alveolar macrophages in liquid cultures  (47) has 
not been investigated,  but it is possible that  the one factor is responsible for 
growth of macrophages in all culture systems. 
The results presented here indicate  that  macrophages,  from an  undifferen- 
tiated precursor cell to the mature differentiated macrophage, are under regula- 
tion by the same molecular species. If the molecular species responsible for CSF 
and MGF activity are the same, the difference then appears to reside in the test 
cells. Activated macrophages have a  longer doubling time than  CFU-C in the 
presence of the factor, and they respond maximally at twice the factor concen- 
tration  required  for  maximal  response  of CFU-C.  If receptor  molecules  are 
involved in the stimulation by CSF or MGF, an attractive hypothesis would be 
that their distribution or density change as the target cells progress to the final 
macrophage state. The differences in response would then not be due to different 
substances, but to cells of the same lineage,  which,  at different stages of their 
maturation,  are programmed to respond by proliferating according to different 
concentrations of the same group of substances. 
Positive regulation  of macrophage  production  ought  to  be homeostatically 
linked to the requirements  of the organism.  In this context, it is of interest to 
consider the release of CSF and MGF. Peritoneal macrophages from unstimu- 
lated mice are a  good source from which the release of CSF is largely antigen 
dependent  (48). Maximal  release  of CSF  from  adherent  macrophages  occurs 
within  3  h  of exposure  to  endotoxin,  and  the  degree  of release  is  related  to 
endotoxin concentration (48). The release is only slightly inhibited by puromycin 
(49) compatible with a cell surface localization of CSF, as reported for MGF on L 
cells (10).  It is attractive to consider the regulation of macrophage differentia- 
tion  in  terms  of positive  feedback  via  the  antigen  concentration-dependent 
release of a  regulator from mature macrophages. 
The  CSF-MGF system offers a  potentially valuable means of analyzing  the 
precise operation of a  regulator molecule on eukaryote cell differentiation and 
proliferation.  In addition,  since CSF levels are elevated quickly and dramati- 
cally  on  antigen  stimulation,  it  is  pertinent  to  the  study  of immunological 
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Summary 
The activities of a colony-stimulating factor (CSF), which stimulates granulo- 
cyte-macrophage colony formation by mouse hemopoietic cells, and macrophage 
growth  factor  (MGF),  which  stimulates  proliferation  of activated  peritoneal 
macrophages, have been demonstrated by various criteria to reside in the same 
molecular  species.  These  criteria  include  occurrence  in  various  sources  and 
copurification of the activities in mouse L-cell-conditioned medium as well as 
the biological, physicochemical, and antigenic properties of the activities of L- 
cell-conditioned medium. CSF and MGF activities of L-cell-conditioned medium 
are ascribable to a glycoprotein of mol wt approximately 60,000 which migrates 
electrophoretically with a-globulin.  Human urinary CSF, which also possesses 
MGF activity, has  similar properties and can be neutralized by antiserum  to 
highly  purified  L-cell medium  CSF.  A  procedure is  described for the  partial 
purification of material from L-cell medium that has activity at 1 ng/ml in both 
MGF and CSF assays. 
Note Added in Proof.  Further purification of L-cell-conditioned medium CSF has resulted in a 
preparation that is pure as assessed by isoelectric focusing, SDS polyacrylamide gel electrophore- 
sis, and immunological criteria. The purified CSF possesses MGF activity and stimulates colony 
formation by thioglycolate-induced peritoneal  cells (E. R. Stanley and P. M. Heard, manuscript 
in preparation). 
We wish to thank Dr. E. Bikoff for her helpful comments in the preparation of  this manuscript. 
Received for publication 12 November 1975. 
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